Lippens, Guy
Centre National de la Recherche Scientifique · Institut National des Sciences Appliquées de Toulouse · Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
9 papers on CoChatORCID 0000-0002-8236-0901
Most cited papers
- Verified
Post‐translational modification: nature's escape from genetic imprisonment and the basis for dynamic information encoding
Prabakaran, S., Lippens, G., Steen, H., & Gunawardena, J. (2012) · WIREs Systems Biology and Medicine
Protein Structure and DynamicsAdvanced Proteomics Techniques and Applications
Cited by 335
- Verified
Mice lacking phosphatase PP2A subunit PR61/B’δ ( Ppp2r5d ) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3β
Louis, J. V., Martens, E., Borghgraef, P., Lambrecht, C., Sents, W., Longin, S., Zwaenepoel, K., Pijnenborg, R., Landrieu, I., Lippens, G., et al. (2011) · Proceedings of the National Academy of Sciences
Alzheimer's disease research and treatmentsProtein Kinase Regulation and GTPase Signaling
Cited by 112
- Verified
Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules
Amniai, L., Barbier, P., Sillen, A., Wieruszeski, J.-M., Peyrot, V., Lippens, G., & Landrieu, I. (2009) · The FASEB Journal
Alzheimer's disease research and treatmentsMicrotubule and mitosis dynamics
Cited by 105
- Verified
Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain
Sottejeau, Y., Bretteville, A., Cantrelle, F.-X., Malmanche, N., Demiaute, F., Mendes, T., Delay, C., Alves Dos Alves, H., Flaig, A., Davies, P., et al. (2015) · Acta Neuropathologica Communications
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 98
- Verified
Glycan Determinants of Heparin-Tau Interaction
Zhao, J., Huvent, I., Lippens, G., Eliezer, D., Zhang, A., Li, Q., Tessier, P., Linhardt, R. J., Zhang, F., & Wang, C. (2017) · Biophysical Journal
Alzheimer's disease research and treatmentsGlycosylation and Glycoproteins Research
Cited by 87
- Verified
Spectroscopic Studies of GSK3β Phosphorylation of the Neuronal Tau Protein and Its Interaction with the N-Terminal Domain of Apolipoprotein E
Leroy, A., Landrieu, I., Huvent, I., Legrand, D., Codeville, B., Wieruszeski, J.-M., & Lippens, G. (2010) · Journal of Biological Chemistry
Alzheimer's disease research and treatmentsProtein Kinase Regulation and GTPase Signaling
Cited by 86
- Verified
Tau Aggregation in Alzheimer's Disease: What Role for Phosphorylation?
Lippens, G., Sillen, A., Landrieu, I., Amniai, L., Sibille, N., Barbier, P., Leroy, A., Hanoulle, X., & Wieruszeski, J.-M. (2007) · Prion
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 68
- Verified
Regulation of the interaction between the neuronal BIN 1 isoform 1 and Tau proteins – role of the SH 3 domain
Malki, I., Cantrelle, F., Sottejeau, Y., Lippens, G., Lambert, J., & Landrieu, I. (2017) · The FEBS Journal
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 54
- Verified
Rules of Coexistence: RiPP Recognition Elements Evolved to Prevent Pathway Interference through Leader Peptide Discrimination
Dubiley, S., Popov, A., Bikmetov, D., Grigoreva, A., Serebryakova, M., Severinov, K., Lippens, G., Wada, A., & Tagami, S. (2025) · Nature Communications
Microbial Natural Products and BiosynthesisAntimicrobial Peptides and Activities
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free